RecruitingNot ApplicableNCT07553273

Vibratory Anesthesia on Pain Following Corticosteroid Injections

The Effect of Vibratory Anesthesia on Patient Pain Perception in Corticosteroid Injections of the Upper Extremity

Sponsor

The University of Texas Medical Branch, Galveston

Enrollment

165 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Arthropathy Bilateral Arthritis of Wrist Compression Neuropathy Bilateral Arthritis of Hands Tendinopathy

Summary

This research study aims to evaluate injectional pain at the site of needle insertion for corticosteroid injections (CSI) of the upper extremity depending on different modes of anesthetics. Each individual's perception of pain upon receiving a CSI with two out of three modes of anesthesia (control/no anesthesia, vibrational anesthesia, vapo-coolant anesthesia) will be utilized to compare these variables and determine the method that is associated with the least pain.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Any patient of the Principal Investigator, Dr. John Faillace, who has clinically diagnosed bilateral arthritis, tendinopathy, arthropathy, or compression neuropathy of the hand, wrist, or elbow where treatment with corticosteroid injection is indicated.
Participants who voluntarily consent to participate in the study and sign consent forms.
Participants who complete all numeric pain rating scales
Patients aged ≥ 18 years old

Exclusion Criteria7

Participants who opt out of the study or withdraw consent
Participants who are determined to be without capacity to consent to study participation or injection procedure by principal investigator
Participants with inability to complete numeric pain rating scales
Participants with known allergies to triamcinolone acetonide, lidocaine, or bupivicaine
Participants without clinically diagnosed bilateral arthritis, tendinopathy, arthropathy, or compression neuropathy of the hand, wrist, or elbow.
Participants where treatment with corticosteroid injection is not indicated bilaterally.
Patients ≤ 18 years old

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDigivibe Device

The Digivibe device uses pulsed vibrations to activate larger nerve fibers to inferfere with pain signals. It has a circular shape to allow for injections in an area surrounded by pain-blocking vibrations.